ArticleJournal of clinical medicine2024

A Feasibility Open-Labeled Clinical Trial Using a Second-Generation Artificial-Intelligence-Based Therapeutic Regimen in Patients with Gaucher Disease Treated with Enzyme Replacement Therapy.

Noa Hurvitz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.